BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27789518)

  • 1. High prevalence of insomnia and hypnotic use in patients visiting their general practitioner.
    Bjorvatn B; Meland E; Flo E; Mildestvedt T
    Fam Pract; 2017 Feb; 34(1):20-24. PubMed ID: 27789518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of insomnia and hypnotic use in Norwegian patients visiting their general practitioner.
    Torsvik S; Bjorvatn B; Eliassen KE; Forthun I
    Fam Pract; 2023 Mar; 40(2):352-359. PubMed ID: 36124938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 10-year trend of insomnia prevalence in the adult Norwegian population.
    Pallesen S; Sivertsen B; Nordhus IH; Bjorvatn B
    Sleep Med; 2014 Feb; 15(2):173-9. PubMed ID: 24382513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland.
    Linnet K; Gudmundsson LS; Birgisdottir FG; Sigurdsson EL; Johannsson M; Tomasdottir MO; Sigurdsson JA
    BMC Fam Pract; 2016 Jun; 17():69. PubMed ID: 27267943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insomnia and hypnotic use in Campo Grande general population, Brazil.
    Souza JC; Magna LA; Reimao R
    Arq Neuropsiquiatr; 2002 Sep; 60(3-B):702-7. PubMed ID: 12364933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypnotics].
    Uchiyama M
    Nihon Rinsho; 2012 Jan; 70(1):52-7. PubMed ID: 22413492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypnotic prescription by GPs is associated with their personal drug consumption but not by their insomnia status.
    Chambe J; Kobayashi Frisk M; Charton L; Lefebvre F; Will S; Rat C; Bourgin P
    J Sleep Res; 2020 Aug; 29(4):e12993. PubMed ID: 32048384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased prevalence of insomnia and changes in hypnotics use in England over 15 years: analysis of the 1993, 2000, and 2007 National Psychiatric Morbidity Surveys.
    Calem M; Bisla J; Begum A; Dewey M; Bebbington PE; Brugha T; Cooper C; Jenkins R; Lindesay J; McManus S; Meltzer H; Spiers N; Weich S; Stewart R
    Sleep; 2012 Mar; 35(3):377-84. PubMed ID: 22379244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sleep disorders and hypnotic agents: medical, social and economical impact].
    Touitou Y
    Ann Pharm Fr; 2007 Jul; 65(4):230-8. PubMed ID: 17652991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of insomnia and use of sleep medicines in urban communities of Karachi, Pakistan.
    Kidwai R; Ahmed SH
    J Pak Med Assoc; 2013 Nov; 63(11):1358-63. PubMed ID: 24392519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insomnia and use of hypnotics: study of a French population.
    Quera-Salva MA; Orluc A; Goldenberg F; Guilleminault C
    Sleep; 1991 Oct; 14(5):386-91. PubMed ID: 1759090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multinational study of sleep disorders during female mid-life.
    Blümel JE; Cano A; Mezones-Holguín E; Barón G; Bencosme A; Benítez Z; Bravo LM; Calle A; Flores D; Espinoza MT; Gómez G; Hernández-Bueno JA; Laribezcoa F; Martino M; Lima S; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Sánchez H; Tserotas K; Vallejo MS; Witis S; Zúñiga MC; Chedraui P
    Maturitas; 2012 Aug; 72(4):359-66. PubMed ID: 22717489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of quality of sleep and the use of drugs with sedating properties in hospitalized adult patients.
    Frighetto L; Marra C; Bandali S; Wilbur K; Naumann T; Jewesson P
    Health Qual Life Outcomes; 2004 Mar; 2():17. PubMed ID: 15040803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General practitioners' preferences for managing insomnia and opportunities for reducing hypnotic prescribing.
    Siriwardena AN; Apekey T; Tilling M; Dyas JV; Middleton H; Ørner R
    J Eval Clin Pract; 2010 Aug; 16(4):731-7. PubMed ID: 20545802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: a nationwide population-based follow-up study.
    Chung KH; Li CY; Kuo SY; Sithole T; Liu WW; Chung MH
    J Clin Sleep Med; 2015 Apr; 11(5):543-51. PubMed ID: 25766696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and associations of multiple hypnotic prescriptions in a clinical sample.
    Kolla BP; Mansukhani MP; Chakravorty S; Frank JA; Coombes BJ
    J Clin Sleep Med; 2024 May; 20(5):793-800. PubMed ID: 38189358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insomnia symptoms among old people in nursing homes.
    Skottheim A; Lövheim H; Isaksson U; Sandman PO; Gustafsson M
    Int Psychogeriatr; 2018 Jan; 30(1):77-85. PubMed ID: 28927479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and treatment of insomnia in general practice. A longitudinal study.
    Hohagen F; Rink K; Käppler C; Schramm E; Riemann D; Weyerer S; Berger M
    Eur Arch Psychiatry Clin Neurosci; 1993; 242(6):329-36. PubMed ID: 8323982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors contributing to sleep disturbance and hypnotic drug use in hemodialysis patients.
    Noda A; Nakai S; Soga T; Sugiura T; Iwayama N; Maeda K; Atarashi M; Yasuma F; Ozaki N; Yokota M; Koike Y
    Intern Med; 2006; 45(22):1273-8. PubMed ID: 17170500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insomnia in the elderly: reported reasons and their associations with medication in general practice in Denmark.
    Hollsten I; Foldbo BM; Kousgaard Andersen MK; Nexøe J
    Scand J Prim Health Care; 2020 Jun; 38(2):210-218. PubMed ID: 32362206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.